As of Jul 28
| -0.07 / -0.42%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 16.25, with a high estimate of 18.00 and a low estimate of 14.50. The median estimate represents a -1.63% decrease from the last price of 16.52.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.